ApprovalTrail

Approval · Notice of Compliance 4544 · 1996

GLYCON: Notice of Compliance 4544

Issued September 9, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4544
Date
September 9, 1996
Company
Icn Canada Ltd.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Oral antihyperglycemic agent

Products in this notice

BrandDINStatus today
GLYCON02229516Dormant

Medicinal ingredients